Replies to post #2235 on InMed Pharmaceuticals Inc (INM)

[lesgetrich]

That article identifies the difference between InMed's biosynthesis and Teewinot's process...

The traditional method is to grow thousands of plants, purify them and process them, which Adams finds to be very unclean. The other end of the spectrum is creating the compound in a chemical lab to recreate structures, which is also time consuming, very expensive and not quite identical to what nature has given. InMed starts with the cannabinoid DNA and actually puts it into a bacteria called E-coli. The E-coli DNA is removed and then the cannabinoid DNA takes over. Like a pharmaceutical copy machine.